TRIPTORELIN (GNRH)

Overview

Triptorelin is a man-made form of a hormone that regulates many processes in the body. Triptorelin overstimulates the body's own production of certain hormones, which causes that production to shut down temporarily.

Triptorelin is used to treat the symptoms of prostate cancer. Triptorelin treats only the symptoms of prostate cancer and does not treat the cancer itself. Use any other medications your doctor has prescribed to best treat your condition.

Benefits

Triptorelin is a synthetic decapeptide (D-Trp6 GnRH) analogue of natural GnRH. Studies in animals and man have shown that continued administration of triptorelin exerts, after a short initial stimulation, an inhibitory effect on the gonadotropin secretion with consequent suppression of testicular and ovarian function.

The first administration of Decapeptyl 3-month stimulates the release of pituitary gonadotropins with a transient increase in testosterone levels ('flare-up'). Prolonged administration leads to a suppression of gonadotropins and a fall in plasma testosterone to castrate levels after approximately 20 days and which continues for as long as the product is administered.


Dosage

Note; dosage information is only for scientific reference purposes. SARMs Central, does not condone the human consumption or use of this substance outside of a controlled scientific environment (i.e. a lab).

Due to different release characteristics, the dosage strengths are not additive and must be selected based upon the desired dosing schedule.

3.75 mg intramuscularly (IM) every 4 weeks OR 11.25 mg IM every 12 weeks OR 22.5 mg IM every 24 weeks

Potential Side Effects

Common side effects may include:

  • Hot flashes

  • Back pain, pain or swelling in your legs

  • Mild headache, dizziness, tired feeling

  • Decreased interest in sex, impotence, trouble having an orgasm

  • Nausea, vomiting, diarrhea, upset stomach

  • Sleep problems (insomnia)

  • Breast pain or swelling

  • Pain where the medicine was injected

About Author

GIVE A REPLY